Literature DB >> 23358876

Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio.

Satoshi Okumura1, Masaki Sakakibara, Ryo Hayashida, Yasushi Jinno, Akihito Tanaka, Koji Okada, Mutsuharu Hayashi, Hideki Ishii, Toyoaki Murohara.   

Abstract

High low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol (L/H) ratio is associated with progressions of coronary arteriosclerosis and chronic kidney disease. On the other hand, renal function markedly declined after acute myocardial infarction (AMI). The aims of the present study were (1) to identify what type of patients with AMI would have high L/H ratio at follow-up and (2) to evaluate whether decline in renal function after AMI had accelerated or not in patients with high L/H ratio. The 190 eligible AMI patients who underwent primary percutaneous coronary intervention (PCI) and received atorvastatin (10 mg) were divided into one of two groups according to the L/H ratio at 6-month follow-up: L/H >2 group (n = 81) or L/H ≤2 group (n = 109). The characteristics on admission in the two groups were examined. Furthermore, changes in serum creatinine (sCr) and estimated glomerular filtration rate (eGFR) during 1- and 6-month follow-up were compared between the two groups. L/H >2 group were significantly younger and had greater body mass index (BMI) and worse lipid profile on admission compared with L/H ≤2 group. Percentage increase in sCr and percentage decrease in eGFR during 1-month follow-up in L/H >2 group tended to be greater than in L/H ≤2 group, and those during 6-month follow-up were significantly greater (16.5 ± 2.77 vs. 9.79 ± 2.23 %, p = 0.03 and 11.8 ± 1.93 vs. 2.75 ± 3.85 %, p = 0.04, respectively). In AMI patients undergoing primary PCI, those who were young and had large BMI and poor lipid profile on admission were likely to have a high L/H ratio at follow-up despite statin therapy. In addition, the decline in renal function after AMI had significantly accelerated in patients with high L/H ratio.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358876     DOI: 10.1007/s00380-012-0321-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  40 in total

1.  High-density lipoproteins prevent the oxidized low-density lipoprotein-induced epidermal [corrected] growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation.

Authors:  Fanny Robbesyn; Nathalie Augé; Cécile Vindis; Anne-Valérie Cantero; Ronald Barbaras; Anne Negre-Salvayre; Robert Salvayre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-07       Impact factor: 8.311

2.  The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.

Authors:  Parin J Patel; Amit V Khera; Kashif Jafri; Robert L Wilensky; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

Review 3.  Statins and renal diseases: from primary prevention to renal replacement therapy.

Authors:  Giuseppe D'Amico
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

4.  Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney disease.

Authors:  Richard A Zager; Ali C M Johnson; Kirsten Becker
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-14

5.  Effects of hypertension and dyslipidemia on the decline in renal function.

Authors:  M Mänttäri; E Tiula; T Alikoski; V Manninen
Journal:  Hypertension       Date:  1995-10       Impact factor: 10.190

Review 6.  Pleiotropic effects of statins. - Basic research and clinical perspectives -.

Authors:  Qian Zhou; James K Liao
Journal:  Circ J       Date:  2010-04-15       Impact factor: 2.993

7.  Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.

Authors:  Gregg C Fonarow; R Scott Wright; Frederick A Spencer; Paul D Fredrick; Wei Dong; Nathan Every; William J French
Journal:  Am J Cardiol       Date:  2005-09-01       Impact factor: 2.778

8.  The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol.

Authors:  Mehmet Kanadaşi; Murat Cayli; Mustafa Demirtaş; Tamer Inal; Mesut Demir; Mevlut Koç; Mahir Avkaroğullari; Yurdaer Dönmez; Ayhan Usal; Cumhur C Alhan; Mustafa San
Journal:  Heart Vessels       Date:  2006-09-29       Impact factor: 2.037

9.  Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

Authors:  Stephen J Nicholls; E Murat Tuzcu; Ilke Sipahi; Adam W Grasso; Paul Schoenhagen; Tingfei Hu; Kathy Wolski; Tim Crowe; Milind Y Desai; Stanley L Hazen; Samir R Kapadia; Steven E Nissen
Journal:  JAMA       Date:  2007-02-07       Impact factor: 56.272

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  3 in total

1.  Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).

Authors:  Mitsuhiro Shimomura; Jun-Ichi Oyama; Masayoshi Takeuchi; Yoshisato Shibata; Yusuke Yamamoto; Tomohiro Kawasaki; Hiroshi Komoda; Kazuhisa Kodama; Masashi Sakuma; Shigeru Toyoda; Yohei Inoue; Daigo Mine; Masahiro Natsuaki; Aiko Komatsu; Yutaka Hikichi; Sho-Ichi Yamagishi; Teruo Inoue; Koichi Node
Journal:  Heart Vessels       Date:  2015-12-23       Impact factor: 2.037

2.  Prevalence, implication, and determinants of worsening renal function after surgery for congenital heart disease.

Authors:  Hirofumi Saiki; Seiko Kuwata; Clara Kurishima; Yoichi Iwamoto; Hirotaka Ishido; Satoshi Masutani; Hideaki Senzaki
Journal:  Heart Vessels       Date:  2015-08-13       Impact factor: 2.037

3.  Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction.

Authors:  Mutsuharu Hayashi; Yoshinari Yasuda; Susumu Suzuki; Manaka Tagaya; Takehiro Ito; Tomohito Kamada; Masataka Yoshinaga; Yoshinori Sugishita; Wakaya Fujiwara; Hiroatsu Yokoi; Yukio Ozaki; Hideo Izawa
Journal:  Heart Vessels       Date:  2016-07-06       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.